comorbidity

shutterstock_135966185

Introduction

Comorbidity, or the co-occurrence of two distinct medical conditions, is a common phrase in both physical and mental health. Whilst the term was originally conceived to describe medical phenomena, the term was adopted by psychiatry in the description of more than one clinical presentation occurring simultaneously. However, its use in psychiatry is not without controversy. 

What we know already

Large-scale prevalence data can seemingly tell us much about the high rate of comorbidity in mental health. Data from US National Comorbidity Survey, for example, suggested that, of those reporting mental health difficulties (across a 12-month prevalence), only 55% carried a single psychiatric diagnosis.

One important area of recent research concerns the rates of comorbidity of physical and mental health difficulties, particularly in the area of chronic health conditions. Mental Elf blogs have reported that people with schizophrenia are significantly more likely to die from heart disease and cancer; while the National Schizophrenia Audit calls for improved monitoring of physical health in people with schizophrenia. We know that depression and anxiety are more common when a person has a chronic health problem, and this comorbidity leads to poorer clinical and quality of life outcomes. This has led to an increase in interventions targeting the psychological consequences of chronic ill health.

Areas of uncertainty

The controversy in psychiatric comorbidity is the issues of mutual exclusivity. We are not able to conclude as to whether ‘comorbid’ psychiatric diagnoses are separate clinical entities, or multiple features of the same underlying cause. This has led to much criticism of the term ‘psychiatric comorbidity’.

Furthermore, certain diagnostic labels, such as personality disorders, attract particular scrutiny, due to their high levels of comorbidity with other mental health diagnoses. Similarly, people often meet the criteria for more than one personality disorder. This again creates uncertainty as to the precise nature of the condition, or conditions, being diagnosed.

What’s in the pipeline?

The recent publication of the Diagnostic and Statistic Manual (DSM)-5 seemingly retains the notion that multiple distinct clinical diagnoses exist, thus maintaining the argument for psychiatric comorbidity. Alternative conceptualisations have been suggested, along dimensional models, such as ‘anxious-misery’, ‘externalising’ and ‘fear-based’ dimensions. However, these were not adopted in the DSM-5.

As our understanding of mental health conditions continues to improve, so too hopefully will our understanding of comorbidity, and its relevance to psychological and psychiatric phenomena.

References

First, M. B. (2005). Mutually exclusive versus co-occurring diagnostic categories: the challenge of diagnostic comorbidity. Psychopathology, 38, 206-210. [Abstract]

Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of general psychiatry, 62, 617-627. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK. [Full text]

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Sep 2015
Review due: Sep 2016

Our comorbidity Blogs

Death from COVID-19: should we be prioritising people with schizophrenia for vaccination?

Westminster,,London,|,Uk,-,2021.04.17:,Lady,Writing,Names,On

In her debut blog, Aneta Zarska reviews a cohort study which looks at the links between death from COVID-19 and a range of mental health conditions, including schizophrenia, depression and anxiety.

[read the full story...]

Multimorbidity: does depression predict the onset of physical illness?

shutterstock_1499312150

Lydia Poole reviews a recent Canadian study examining depression as a risk factor for physical illness and multimorbidity in a cohort with no prior comorbidity.

[read the full story...]

Maudsley guidelines for physical health

Best Practice concept. Magnifying Glass on Old Paper with Red Vertical Line Background.

“There are many other ways to get our patients better than prescribing and talking.”

Shuichi Suetani reviews a recently published textbook: The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry.

[read the full story...]

Drug treatment of ADHD in children and young people with ASD #CAMHScampfire

Mental Health Awareness concept for ADHD. letters spelling ADHD.

Douglas Badenoch appraises an up-to-date systematic review and decision pathway for the drug treatment of ADHD symptoms in young people with autism spectrum disorder.

Follow #CAMHScampfire on Twitter at 5pm BST on Tuesday 25th May for an online journal club discussing this paper. Or sign up now to join the free webinar hosted by ACAMH.

[read the full story...]

Mental disorders start early and vary across the lifespan: it’s time to pay attention to the whole person, and less to the diagnosis #IoPPNfestival

pawel-szvmanski-vuwLcfHVk5Y-unsplash

In her debut blog, Dona Matthews reviews a longitudinal cohort study by Caspi and Moffitt which explores how mental disorders and comorbidities have affected over one thousand people in New Zealand across four decades.

This Dunedin birth cohort study research will be presented by Prof Terrie Moffitt at the #IoPPNfestival later today.

[read the full story...]

Increased risk for physical illness in schizophrenia is not caused by genetic liability for the disorder: according to new data-linkage study

sharon-pittaway-4_hFxTsmaO4-unsplash

Dolly Sud appraises a recent data linkage study on the impact of schizophrenia genetic liability on the association between schizophrenia and physical illness.

[read the full story...]

Inflammation and depression in young people #ActiveIngredientsMH

maria-clara-araruna-Y1QdOLp65AY-unsplash

Yara Toenders and Lianne Schmaal consider the links between inflammatory dysregulation and depression in young people, by reviewing a recent study carried out by researchers in the US, and also by presenting the results of their own recent #ActiveIngredientsMH review, which was funded by the Wellcome Trust.

[read the full story...]

“Personality disorders” more common in people with immune-mediated inflammatory diseases

Portrait,Elegant,Attractive,Mature,Woman,With,Sad,Lonely,Concerned,Depressed

Jonathan Monk-Cunliffe explores a recent cohort study which finds that people with inflammatory diseases such as multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease are at greater risk of “personality disorder”.

[read the full story...]

Can psilocybin-assisted psychotherapy relieve existential crises in cancer patients?

sharon-mccutcheon-iNlgy1WkfJA-unsplash

Pascal Immanuel Michael reviews a randomised controlled trial examining long-term outcomes of psilocybin-assisted psychotherapy for existential distress in patients with cancer.

[read the full story...]

Stay fit in response to COVID: simple recommendations and COH-FIT

shutterstock_1369256174

Marco Solmi tells us about the importance of physical activity as people in the UK enter a second period of coronavirus lockdown.

He also introduces us to the huge international COH-FIT study, which will help us better understand how the pandemic is affecting people and what can help.

[read the full story...]